Seven studies provided effective clinicopathological characteristics and conducted a detailed quantitative analysis.[10,11,15,17–20] The statistical results indicated that there was no association between the expression level of CASC11 and age, sex, tumor size, or lymph node metastasis. This evidence concerns the gene CASC11 and neoplasm.